S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
My No. 1 dividend stock for a LIFETIME of income. (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Biden's pick to lead FAA withdraws amid shaky Senate support
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Turkmenistan votes for new, opposition-free parliament
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
My No. 1 dividend stock for a LIFETIME of income. (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Biden's pick to lead FAA withdraws amid shaky Senate support
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Turkmenistan votes for new, opposition-free parliament
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
My No. 1 dividend stock for a LIFETIME of income. (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Biden's pick to lead FAA withdraws amid shaky Senate support
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Turkmenistan votes for new, opposition-free parliament
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
My No. 1 dividend stock for a LIFETIME of income. (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Biden's pick to lead FAA withdraws amid shaky Senate support
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Turkmenistan votes for new, opposition-free parliament
Adele extends Las Vegas residency, plans concert film
TSE:CRON

Cronos Group - CRON Stock Forecast, Price & News

C$2.67
+0.05 (+1.91%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
C$2.59
▼
C$2.67
50-Day Range
C$2.57
▼
C$3.43
52-Week Range
C$2.53
▼
C$5.36
Volume
163,912 shs
Average Volume
300,364 shs
Market Capitalization
C$1.02 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$4.71

CRON stock logo

About Cronos Group (TSE:CRON) Stock

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

March 20, 2023 | finance.yahoo.com
Cronos Group Inc.'s (TSE:CRON) largest shareholders are public companies with 41% ownership, individual investors own 41%
March 13, 2023 | marketwatch.com
Cronos Group Inc. stock rises Monday, outperforms market
March 26, 2023 | Oxford Club (Ad)
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
March 10, 2023 | marketwatch.com
Cultivation and Processing of Canabis Market to 2023-2028
March 1, 2023 | marketwatch.com
Cronos Group Inc. stock falls Wednesday, underperforms market
February 28, 2023 | finance.yahoo.com
Cronos Group Inc.: Cronos' Earnings: Respectable Progress on Narrowing Losses but Positive EBITDA Remains Years Away
February 28, 2023 | marketwatch.com
Cronos Group Inc. stock rises Tuesday, outperforms market
February 28, 2023 | finance.yahoo.com
Cronos Group (CRON) Q4 2022 Earnings Call Transcript
March 26, 2023 | Behind the Markets (Ad)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
February 28, 2023 | finance.yahoo.com
Top Cannabis Stocks for March 2023
February 28, 2023 | marketwatch.com
Cronos Group 4Q Loss Narrows, Revenue Declines in Line With Views
February 28, 2023 | markets.businessinsider.com
Cronos Q4 2022 Revenue Declines 11% YoY, What About Net Loss?
February 27, 2023 | msn.com
Earnings Preview For Cronos Group
February 9, 2023 | msn.com
Create a Stream of Passive Income with These Proven Winning Stocks
February 6, 2023 | finance.yahoo.com
Altria Group, Inc.: Maintaining HOLD following 4Q results
January 26, 2023 | msn.com
CDC denies bids to market CBD products as dietary supplements
January 24, 2023 | marketwatch.com
Cronos Group Inc. stock falls Tuesday, underperforms market
December 19, 2022 | msn.com
Altria to claim $483 mln capital loss on cannabis company ownership stake
December 7, 2022 | seekingalpha.com
Cronos Group Inc. (CRON) Stifel Canada Future of Healthcare Conference Transcript
December 6, 2022 | finance.yahoo.com
Down 76% This Year, Is This Growth Stock Now a Screaming Buy?
December 5, 2022 | finance.yahoo.com
Crypto Rally Continues With Cronos, The Sandbox, and Axie Infinity Surging Today
November 21, 2022 | fool.com
Searching for Huge Passive Income? Buy This Dividend King
November 18, 2022 | finance.yahoo.com
Crypto Contagion Concerns Sink Cronos, Curve, and Polygon This Week
November 16, 2022 | msn.com
Cannabis Stock Movers For November 16, 2022
November 7, 2022 | seekingalpha.com
Cronos Group Inc. (CRON) Q3 2022 Earnings Call Transcript
November 7, 2022 | finance.yahoo.com
Top Cannabis Stocks
November 7, 2022 | markets.businessinsider.com
Cronos Q3 Revenue Stagnates, Remains On Track For $20M In Operating Expense Savings
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:CRON
CUSIP
N/A
CIK
N/A
Web
www.thecronosgroup.com
Phone
416-504-0004
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$4.71
High Stock Price Forecast
C$7.00
Low Stock Price Forecast
C$3.19
Forecasted Upside/Downside
+76.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
C($0.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
0.12
Net Income
C$-168,730,000.00
Net Margins
-183.60%
Pretax Margin
N/A
Return on Equity
-13.63%
Return on Assets
-5.55%

Debt

Debt-to-Equity Ratio
0.34
Current Ratio
14.10
Quick Ratio
24.01

Sales & Book Value

Annual Sales
C$91.90 million
Price / Sales
11.06
Cash Flow
C$1.60 per share
Price / Cash Flow
1.67
Book Value
C$3.01 per share
Price / Book
0.89

Miscellaneous

Outstanding Shares
380,580,000
Free Float
N/A
Market Cap
C$1.02 billion
Optionable
Optionable
Beta
1.44

Key Executives

  • Mr. Michael Ryan Gorenstein J.D. (Age 36)
    Pres, CEO & Chairman
    Comp: $389.15k
  • Ms. Shannon Buggy (Age 53)
    Sr. VP & Global Head of People
    Comp: $438.81k
  • Ms. Anna Shlimak (Age 37)
    Sr. VP of Corp. Affairs & Strategy
    Comp: $422.03k
  • Mr. James Holm
    Chief Financial Officer
  • Mr. Carlos Cortez (Age 50)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 33)
    Sr. VP of Legal & Regulatory Affairs and Corp. Sec.
  • Mr. Jeffrey David Jacobson (Age 37)
    Chief Growth Officer
  • Mr. Arye Weigensberg
    Head of R&D
  • Mr. Kevin B Gifford
    VP of Fin.

Key Competitors

View All Competitors













CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRON shares.
View CRON analyst ratings or view top-rated stocks.

What is Cronos Group's stock price forecast for 2023?

3 Wall Street analysts have issued twelve-month target prices for Cronos Group's shares. Their CRON share price forecasts range from C$3.19 to C$7.00. On average, they predict the company's stock price to reach C$4.71 in the next year. This suggests a possible upside of 76.5% from the stock's current price.
View analysts price targets for CRON or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2023?

Cronos Group's stock was trading at C$3.44 at the beginning of the year. Since then, CRON shares have decreased by 22.4% and is now trading at C$2.67.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC).

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$2.67.

How much money does Cronos Group make?

Cronos Group (TSE:CRON) has a market capitalization of C$1.02 billion and generates C$91.90 million in revenue each year. The company earns C$-168,730,000.00 in net income (profit) each year or C($0.62) on an earnings per share basis.

How many employees does Cronos Group have?

The company employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is Suite 300, Toronto, Ontario M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at 416-504-0004.

This page (TSE:CRON) was last updated on 3/26/2023 by MarketBeat.com Staff